Zobrazeno 1 - 10
of 28
pro vyhledávání: '"de Rocquancourt, A."'
Autor:
Nouri-Neuville, M., de Rocquancourt, A., Cohen-Zarade, S., Chapellier-Canaud, M., Albiter, M., Hamy, A.-S., Giachetti, S., Cuvier, C., Espié, M., de Kerviler, É., de Bazelaire, C.
Publikováno v:
In Journal de Radiologie diagnostique et interventionnelle February 2014 95(2):201-216
Autor:
Nouri-Neuville, M., de Rocquancourt, A., Cohen-Zarade, S., Chapellier-Canaud, M., Albiter, M., Hamy, A.-S., Giachetti, S., Cuvier, C., Espié, M., de Kerviler, É., de Bazelaire, C.
Publikováno v:
In Diagnostic and Interventional Imaging February 2014 95(2):197-211
Autor:
A de Rocquancourt, M. Chapellier-Canaud, C. de Bazelaire, Caroline Cuvier, E. de Kerviler, S Cohen-Zarade, Anne-Sophie Hamy, M. Albiter, S Giachetti, M Nouri-Neuville, M. Espie
Publikováno v:
Diagnostic and Interventional Imaging. 95(2):197-211
The term “second look” lesions in MRI refers to lesions detected by MRI that were not initially seen on mammography or ultrasound. The objectives of our study were to analyse the displacement of targets between MRI and ultrasound; to define discr
Autor:
Anne-Sophie Hamy, A de Rocquancourt, S Cohen-Zarade, S Giachetti, C. de Bazelaire, M. Espie, M Nouri-Neuville, M. Chapellier-Canaud, E. de Kerviler, M. Albiter, Caroline Cuvier
Publikováno v:
Journal de Radiologie Diagnostique et Interventionnelle. 95:201-216
Resume Introduction/objectif Le terme lesions de second look en IRM mammaire indique qu’il s’agit de lesions detectees en IRM non vues initialement en mammographie et en echographie. Les objectifs de notre etude etaient d’analyser le deplacemen
Publikováno v:
In Annals of Oncology October 1999 10(10):1241-1243
Publikováno v:
The Breast. 5:277-281
We report a case of inflammatory breast cancer in an 11-year-old girl. She was treated with chemotherapy, surgery and radiotherapy, followed by intensification and autologous bone marrow transplantation. She relapsed 8 months after the end of treatme
Autor:
Fabien Calvo, J.M. Extra, A. de Rocquancourt, E. Bourstyn, G Linares, Marc Espié, P. de Cremoux, Annick Faille, Sylvie Giacchetti, Michel Marty
Publikováno v:
British Journal of Cancer
Alterations in the p53 gene were analysed in 39 patients with locally advanced breast cancers (LABCs) (stage III-IV) with inflammatory signs in most cases (UICC stage T4d = 32 patients) by molecular and immunohistochemical (IHC) approaches. All patie
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 10(10)
Large data base registries have shown that up to 20% of women with breast cancer have one affected relative and estimate that 5% of breast cancers are attributable to major genes such as BRCA1 or BRCA2 [1]. The management of familial breast cancers r
Autor:
S, Culine, J M, Extra, M, Espie, E, Bourstyn, V, Dieras, S, Giacchetti, C, Maylin, A, De Rocquancourt, F, Morvan, M, Marty
Publikováno v:
Bulletin du cancer. 80(11)
Forty-eight patients with inflammatory breast cancer were treated by an induction regimen with cyclophosphamide (1200 mg/m2), and epirubicin (75 mg/m2). Four to six courses were given every two weeks, whatever the absolute leukocyte counts, before ma
Autor:
P.-B. Bourrier, M. Marty, A.-D. De Rocquancourt, C. Maylin, Marc Espié, Z.Z. Zhu, E.-S. Sarfati, C. Hennequin
Publikováno v:
Cancer/Radiothérapie. 12:717